Related Experiment Videos

Stenotrophomonas maltophilia: an increasing problem in patients with acute leukaemia

A Sefcick1, R C Tait, B Wood

  • 1Department of Haematology, Southern General Hospital, Glasgow, Scotland, UK.

Leukemia & Lymphoma
|October 8, 1999
PubMed

Insights

Stenotrophomonas maltophilia infections are a growing concern in immunocompromised patients, particularly those with acute leukaemia. Early antibiotic treatment with cotrimoxazole and central venous catheter removal are crucial for managing these difficult-to-treat infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Oncology

Background:

  • Stenotrophomonas maltophilia is an opportunistic pathogen increasingly implicated in infections among immunocompromised individuals, notably those with acute leukaemia.
  • The pathogen exhibits significant intrinsic and acquired antibiotic resistance, complicating treatment and eradication strategies.
  • Unusual cutaneous manifestations are common in S. maltophilia infections and can pose diagnostic challenges.

Observation:

  • This report details two cases of S. maltophilia infection in leukaemic patients.
  • The cases illustrate classical clinical presentations of this infection.
  • Diagnostic difficulties associated with cutaneous lesions were noted.

Findings:

  • S. maltophilia poses a significant challenge in immunocompromised patients, especially those with acute leukaemia.
  • Infections are characterized by antibiotic resistance, making treatment difficult.
  • Cutaneous lesions are a common and diagnostically challenging presentation.

Implications:

  • Early and appropriate antibiotic therapy, including cotrimoxazole, is essential for effective management.
  • Prompt removal of central venous catheters should be considered in cases of S. maltophilia infection.
  • Increased awareness and diagnostic vigilance are necessary for timely intervention in at-risk patient populations.

Related Concept Videos